192 related articles for article (PubMed ID: 26220665)
61. Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis.
Valleala H; Mandelin J; Laasonen L; Koivula MK; Risteli J; Konttinen YT
Eur J Endocrinol; 2003 May; 148(5):527-30. PubMed ID: 12720535
[TBL] [Abstract][Full Text] [Related]
62. First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort.
Tobón G; Saraux A; Lukas C; Gandjbakhch F; Gottenberg JE; Mariette X; Combe B; Devauchelle-Pensec V
Arthritis Care Res (Hoboken); 2013 Dec; 65(12):1907-15. PubMed ID: 23861163
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort.
Baillet A; Gossec L; Paternotte S; Etcheto A; Combe B; Meyer O; Mariette X; Gottenberg JE; Dougados M
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):905-12. PubMed ID: 25384758
[TBL] [Abstract][Full Text] [Related]
64. Serum OPG/TRAIL ratio predicts the presence of cardiovascular disease in people with type 2 diabetes mellitus.
Forde H; Davenport C; Rochfort KD; Wallace RG; Durkan E; Agha A; Thompson CJ; Tormey WT; O'Gorman DJ; Cummins PM; Smith D
Diabetes Res Clin Pract; 2022 Jul; 189():109936. PubMed ID: 35662613
[TBL] [Abstract][Full Text] [Related]
65. Correlation Between Baseline Osteoprotegerin Serum Levels and Prognosis of Advanced-Stage Colorectal Cancer Patients.
De Toni EN; Nagel D; Philipp AB; Herbst A; Thalhammer I; Mayerle J; Török HP; Brandl L; Kolligs FT
Cell Physiol Biochem; 2018; 45(2):605-613. PubMed ID: 29402836
[TBL] [Abstract][Full Text] [Related]
66. Circulating Levels of Osteoprotegerin, Osteocalcin and Osteopontin in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Liu LN; Mao YM; Zhao CN; Wang H; Yuan FF; Li XM; Pan HF
Immunol Invest; 2019 Feb; 48(2):107-120. PubMed ID: 30188218
[TBL] [Abstract][Full Text] [Related]
67. Relation of the Serum Levels of DKK-1 and Osteoprotegerin with Bone Mass in Tightly Controlled Rheumatoid Arthritis.
Gómez-Vaquero C; Martín I; Zacarías A; Alía P; Loza E; Carmona L; Narváez J
Curr Rheumatol Rev; 2021; 17(1):101-108. PubMed ID: 33349216
[TBL] [Abstract][Full Text] [Related]
68. Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.
Toffoli B; Fabris B; Bartelloni G; Bossi F; Bernardi S
Mediators Inflamm; 2016; 2016():6529728. PubMed ID: 28070143
[No Abstract] [Full Text] [Related]
69. Moderate alcohol consumption is associated with increased radiological progression in women, but not in men, with early rheumatoid arthritis: results from the ESPOIR cohort (Étude et Suivi des Polyarthrites Indifférenciées Récentes).
Sageloli F; Quesada JL; Fautrel B; Salliot C; Gaudin P; Baillet A
Scand J Rheumatol; 2018 Nov; 47(6):440-446. PubMed ID: 29774784
[TBL] [Abstract][Full Text] [Related]
70. Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer-Participation in Pathogenesis or a Possible Clinical Use?
Mielczarek-Palacz A; Kondera-Anasz Z; Smycz-Kubańska M
Cells; 2020 Mar; 9(3):. PubMed ID: 32143328
[TBL] [Abstract][Full Text] [Related]
71. Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis.
Wu PH; Glerup RI; Svensson MHS; Eriksson N; Christensen JH; Linde T; Ljunggren Ö; Fellström B
Nephrol Dial Transplant; 2022 May; 37(6):1162-1170. PubMed ID: 34086939
[TBL] [Abstract][Full Text] [Related]
72. Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases.
Dutka M; Bobiński R; Wojakowski W; Francuz T; Pająk C; Zimmer K
Heart Fail Rev; 2022 Jul; 27(4):1395-1411. PubMed ID: 34313900
[TBL] [Abstract][Full Text] [Related]
73. Prognostic value of TNF-related apoptosis inducing ligand (TRAIL) in acute coronary syndrome patients.
Osmancik P; Teringova E; Tousek P; Paulu P; Widimsky P
PLoS One; 2013; 8(2):e53860. PubMed ID: 23441146
[TBL] [Abstract][Full Text] [Related]
74. Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.
Fortner RT; Sarink D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Affret A; His M; Boutron-Ruault MC; Boeing H; Trichopoulou A; Naska A; Orfanos P; Palli D; Sieri S; Mattiello A; Tumino R; Ricceri F; Bueno-de-Mesquita HB; Peeters PH; Van Gils CH; Weiderpass E; Lund E; Quirós JR; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Dorronsoro M; Key T; Khaw KT; Rinaldi S; Dossus L; Gunter M; Merritt MA; Riboli E; Kaaks R
BMC Med; 2017 Feb; 15(1):26. PubMed ID: 28173834
[TBL] [Abstract][Full Text] [Related]
75. Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients.
Rauwel B; Degboé Y; Nigon D; Boyer JF; Abravanel F; Izopet J; Combe B; Ruyssen-Witrand A; Constantin A; Cantagrel A; Davignon JL
Arthritis Res Ther; 2020 Jan; 22(1):13. PubMed ID: 31959222
[TBL] [Abstract][Full Text] [Related]
76. Increased OPG expression and impaired OPG/TRAIL ratio in the aorta of diabetic rats.
Vaccarezza M; Bortul R; Fadda R; Zweyer M
Med Chem; 2007 Jul; 3(4):387-91. PubMed ID: 17627577
[TBL] [Abstract][Full Text] [Related]
77. TRAIL and osteoprotegerin: a role in endothelial physiopathology?
Corallini F; Rimondi E; Secchiero P
Front Biosci; 2008 Jan; 13():135-47. PubMed ID: 17981533
[TBL] [Abstract][Full Text] [Related]
78. Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease.
Jono S; Otsuki S; Higashikuni Y; Shioi A; Mori K; Hara K; Hashimoto H; Ikari Y
J Thromb Haemost; 2010 Jun; 8(6):1170-5. PubMed ID: 20230427
[TBL] [Abstract][Full Text] [Related]
79. Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.
Granger B; Combe B; Le Loet X; Saraux A; Guillemin F; Fautrel B
RMD Open; 2016; 2(1):e000245. PubMed ID: 27252898
[TBL] [Abstract][Full Text] [Related]
80. Osteoprotegerin as biomarker for persistence of rheumatoid arthritis.
van Steenbergen HW; van der Helm-van Mil AH
Rheumatology (Oxford); 2016 May; 55(5):949-50. PubMed ID: 26647458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
